Veranex accelerating clinical trials with veeva vault cdms

Global medtech cro gains agility to build studies in-house and make mid-study amendments faster pleasanton, calif. , aug. 30, 2022 /prnewswire/ -- veeva systems (nyse: veev) today announced that veranex is using veeva vault cdms to speed study builds and simplify clinical data management.
VEEV Ratings Summary
VEEV Quant Ranking